Literature DB >> 29392461

Phenotypic differences of amyotrophic lateral sclerosis (ALS) in China and Germany.

Angela Rosenbohm1, Mingsheng Liu2, Gabriele Nagel3, Raphael S Peter3, Bo Cui2, Xiaoguang Li2, Jan Kassubek1, Dietrich Rothenbacher3, Dorothée Lulé1, Liying Cui4,5, Albert C Ludolph6.   

Abstract

OBJECTIVE: The aim of this study is to explore phenotypical differences of amyotrophic lateral sclerosis (ALS) between two cohorts from Germany and China.
METHODS: Registry-based studies of ALS were conducted in South-West Germany from 2010 to 2014 and an ALS clinic in Beijing from 2013 to 2016, respectively. Demographic and clinical features of 663 German and 276 Chinese ALS patients were collected and compared.
RESULTS: Mean age-at-onset was higher in German than in Chinese ALS patients [66.6 years (95% CI 65.7, 67.5) vs. 53.2 years (95% CI 52.0, 54.5)]. Age distribution of ALS patients peaked around 70-74 years in Germany and 50-54 years in China. Bulbar onset was more prevalent among German than among Chinese patients (35.9 vs. 22.8%). Diagnostic delay was higher in the Chinese than in the German study sample (12 vs. 5 months). Cognitive deficits were more pronounced in the Chinese cohort. Both cohorts differed in smoking habits, prevalence of diabetes and in body mass index (BMI).
CONCLUSIONS: The apparent discrepancies between German and Chinese ALS patients (age at onset, gender distribution, bulbar forms, cognitive dysfunction, risk factors) reveal a quite different clinical phenotype in China, maybe due to socioeconomic status, environmental factors or genetic background. The observed differences in phenotype need to be pursued by further epidemiological studies on environmental and genetic risk factors.

Entities:  

Keywords:  Age of onset; Amyotrophic lateral sclerosis; China; Epidemiology; Germany; Registry

Mesh:

Year:  2018        PMID: 29392461     DOI: 10.1007/s00415-018-8735-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  32 in total

Review 1.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

2.  Clinical and genetic features of patients with sporadic amyotrophic lateral sclerosis in south-west China.

Authors:  Deng-Fu Fang; Shu-Shan Zhang; Xiao-Yan Guo; Yan Zeng; Yuan Yang; Dong Zhou; Hui-Fang Shang
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec

3.  The predictors of survival in Chinese amyotrophic lateral sclerosis patients.

Authors:  Qianqian Wei; Xueping Chen; Zhenzhen Zheng; Xiaoyan Guo; Rui Huang; Bei Cao; Yan Zeng; Huifang Shang
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2015-01-12       Impact factor: 4.092

4.  Changes in the clinical features of amyotrophic lateral sclerosis in rural Japan.

Authors:  Natsumi Furuta; Kouki Makioka; Yukio Fujita; Koichi Okamoto
Journal:  Intern Med       Date:  2012-03-01       Impact factor: 1.271

5.  The FAB: a Frontal Assessment Battery at bedside.

Authors:  B Dubois; A Slachevsky; I Litvan; B Pillon
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

6.  Epidemiology of amyotrophic lateral sclerosis in Southern Germany.

Authors:  Angela Rosenbohm; Raphael S Peter; Siegfried Erhardt; Dorothée Lulé; Dietrich Rothenbacher; Albert C Ludolph; Gabriele Nagel
Journal:  J Neurol       Date:  2017-02-20       Impact factor: 4.849

7.  Prognosis and epidemiology of amyotrophic lateral sclerosis: Analysis of a clinic population, 1997-2011.

Authors:  Kim Traxinger; Crystal Kelly; Brent A Johnson; Robert H Lyles; Jonathan D Glass
Journal:  Neurol Clin Pract       Date:  2013-08

Review 8.  Prognostic factors in ALS: A critical review.

Authors:  Adriano Chiò; Giancarlo Logroscino; Orla Hardiman; Robert Swingler; Douglas Mitchell; Ettore Beghi; Bryan G Traynor
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec

Review 9.  Amyotrophic lateral sclerosis and motor neuron syndromes in Asia.

Authors:  N Shahrizaila; G Sobue; S Kuwabara; S H Kim; Carol Birks; D S Fan; J S Bae; C J Hu; M Gourie-Devi; Y Noto; K Shibuya; K J Goh; R Kaji; C P Tsai; L Cui; P Talman; R D Henderson; S Vucic; M C Kiernan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2016-04-19       Impact factor: 10.154

10.  Clinical characteristics and survival pattern of 1,153 patients with amyotrophic lateral sclerosis: experience over 30 years from India.

Authors:  A Nalini; K Thennarasu; M Gourie-Devi; Sandhya Shenoy; Dinkar Kulshreshtha
Journal:  J Neurol Sci       Date:  2008-06-12       Impact factor: 3.181

View more
  7 in total

1.  Use and subjective experience of the impact of motor-assisted movement exercisers in people with amyotrophic lateral sclerosis: a multicenter observational study.

Authors:  Thomas Meyer; Susanne Spittel; André Maier; Marcel Gaudlitz; Torsten Grehl; Ute Weyen; Robert Steinbach; Julian Grosskreutz; Annekathrin Rödiger; Jan Christoph Koch; Teresa Lengenfeld; Patrick Weydt; René Günther; Joachim Wolf; Petra Baum; Moritz Metelmann; Johannes Dorst; Albert C Ludolph; Dagmar Kettemann; Jenny Norden; Ruhan Yasemin Koc; Bertram Walter; Barbara Hildebrandt; Christoph Münch
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

2.  Prognostic factors in ALS: a comparison between Germany and China.

Authors:  Johannes Dorst; Lu Chen; Angela Rosenbohm; Dong-Sheng Fan; Albert C Ludolph; Jens Dreyhaupt; Annemarie Hübers; Joachim Schuster; Jochen H Weishaupt; Jan Kassubek; Burkhard Gess; Thomas Meyer; Ute Weyen; Andreas Hermann; Jürgen Winkler; Torsten Grehl; Tim Hagenacker; Paul Lingor; Jan C Koch; Anne Sperfeld; Susanne Petri; Julian Großkreutz; Moritz Metelmann; Joachim Wolf; Andrea S Winkler; Thomas Klopstock; Matthias Boentert; Siw Johannesen; Alexander Storch; Bertold Schrank; Daniel Zeller; Xiao-Lu Liu; Lu Tang
Journal:  J Neurol       Date:  2019-03-28       Impact factor: 4.849

Review 3.  Current knowledge and recent insights into the genetic basis of amyotrophic lateral sclerosis.

Authors:  Alexander E Volk; Jochen H Weishaupt; Peter M Andersen; Albert C Ludolph; Christian Kubisch
Journal:  Med Genet       Date:  2018-07-13

4.  Novel Intronic Mutations of TBK1 Promote Aberrant Splicing Modes in Amyotrophic Lateral Sclerosis.

Authors:  Ying-Qian Lu; Jian-Min Chen; Han Lin; Shu-Yan Feng; Chun-Hui Che; Chang-Yun Liu; Hua-Pin Huang; Zhang-Yu Zou
Journal:  Front Mol Neurosci       Date:  2022-02-24       Impact factor: 5.639

Review 5.  Cortical Circuit Dysfunction as a Potential Driver of Amyotrophic Lateral Sclerosis.

Authors:  Aurore Brunet; Geoffrey Stuart-Lopez; Thibaut Burg; Jelena Scekic-Zahirovic; Caroline Rouaux
Journal:  Front Neurosci       Date:  2020-04-29       Impact factor: 4.677

6.  The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients.

Authors:  Qianqian Zeng; Jie Shen; Kangzhi Chen; Jinxia Zhou; Qiao Liao; Ke Lu; Jiao Yuan; Fangfang Bi
Journal:  Sci Rep       Date:  2020-08-03       Impact factor: 4.379

7.  Medical cost and healthcare utilization of amyotrophic lateral sclerosis in China: A cohort study based on hospital data from 2015 to 2018.

Authors:  Han Song; Jian-Chao Liu; Zi-Peng Cao; Wen-Jing Luo; Jing-Yuan Chen
Journal:  Medicine (Baltimore)       Date:  2020-11-20       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.